Radiation-induced heart disease (RIHD) is a potentially severe side effect of radiotherapy of thoracic and chest wall tumors. Despite advances in radiation delivery and treatment planning technology, cardiac radiation toxicity remains a key consideration in thoracic radiotherapy. Hence, research is urgently needed to elucidate biological mechanisms and identify potential targets for intervention. Our previous pre-clinical studies in a mast cell-deficient rat model have shown that, contrary to what had been the prevailing assumption, mast cells play a predominantly protective role in RIHD. The overall goal of this project is to uncover the role of three mast cell targets in RIHD. For this purpose, genetic animal models and pharmacological interventions will be used to define the involvement of 1) Proteinase-Activated Receptor (PAR)-2, the receptor that mediates cellular effects of mast cell proteinases;2) bradykinin, a cardioprotective hormone that is formed by mast cell proteinases;and 3) the cardioprotective sensory neuropeptide calcitonin gene-related peptide (CGRP), as part of the neuroimmune interactions that are known to alter cardiac function and disease. Functional, structural, cellular and molecular manifestations of RIHD will be measured after local heart irradiation. These in vivo experiments will be the first to provide mechanistic insight into the protective effects of mast cells in RIHD, providing critical pre-clinical data as a basis for future development of intervention strategies, thereby enhancing the efficacy and safety of thoracic radiotherapy.
Radiation-induced heart disease (RIHD) is a severe side effect of radiotherapy of thoracic and chest wall tumors. This project will investigate underlying mechanisms of RIHD and will provide critical pre-clinical data as a basis for future development of strategies aimed at reducing RIHD, thereby enhancing the efficacy and safety of thoracic radiotherapy.
|Sharma, Sunil; Moros, Eduardo G; Boerma, Marjan et al. (2014) A novel technique for image-guided local heart irradiation in the rat. Technol Cancer Res Treat 13:593-603|
|Hauer-Jensen, Martin (2014) Toward development of interleukin-11 as a medical countermeasure for use in radiological/nuclear emergencies. Dig Dis Sci 59:1349-51|
|Sridharan, Vijayalakshmi; Aykin-Burns, Nukhet; Tripathi, Preeti et al. (2014) Radiation-induced alterations in mitochondria of the rat heart. Radiat Res 181:324-34|
|Sridharan, Vijayalakshmi; Tripathi, Preeti; Sharma, Sunil et al. (2014) Roles of sensory nerves in the regulation of radiation-induced structural and functional changes in the heart. Int J Radiat Oncol Biol Phys 88:167-74|
|Boerma, Marjan; Wang, Junru; Sridharan, Vijayalakshmi et al. (2013) Pharmacological induction of transforming growth factor-beta1 in rat models enhances radiation injury in the intestine and the heart. PLoS One 8:e70479|
|Sridharan, Vijayalakshmi; Sharma, Sunil K; Moros, Eduardo G et al. (2013) Effects of radiation on the epidermal growth factor receptor pathway in the heart. Int J Radiat Biol 89:539-47|
|Sridharan, Vijayalakshmi; Tripathi, Preeti; Sharma, Sunil et al. (2013) Effects of late administration of pentoxifylline and tocotrienols in an image-guided rat model of localized heart irradiation. PLoS One 8:e68762|